Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001389277-25-000004
Filing Date
2025-04-11
Accepted
2025-04-11 12:43:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4916
  Complete submission text file 0001389277-25-000004.txt   6895
Mailing Address 5 ALDERMANBURY SQUARE LONDON X0 EC2V 7BP
Business Address 5 ALDERMANBURY SQUARE LONDON X0 EC2V 7BP 44 207 063 7743
BNP Paribas Asset Management UK Ltd (Filed by) CIK: 0001389277 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 601 PENNSYLVANIA AVENUE NW SOUTH BUILDING, SUITE 900 WASHINGTON DC 20004
Business Address 601 PENNSYLVANIA AVENUE NW SOUTH BUILDING, SUITE 900 WASHINGTON DC 20004 202-756-2245
ASP Isotopes Inc. (Subject) CIK: 0001921865 (see all company filings)

EIN.: 872618235 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94207 | Film No.: 25830760
SIC: 2890 Miscellaneous Chemical Products
(CF Office: 08 Industrial Applications and Services)